cp 46665 has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berdel, WE; Eibl, H; Fink, U; Rastetter, J; Reichert, A; Schick, HD; Unger, C; Von Hoff, DD | 1 |
| Berdel, WE; Fink, U; Rastetter, J; Reichert, A; Schick, HD; Ulm, K | 1 |
2 other study(ies) available for cp 46665 and Neoplasms
| Article | Year |
|---|---|
Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.
Topics: Antineoplastic Agents; Cell Survival; Female; Humans; Lysophosphatidylcholines; Neoplasms; Phospholipid Ethers; Piperidines; Structure-Activity Relationship | 1986 |
Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias.
Topics: Adjuvants, Immunologic; Cell Line; Cell Survival; Humans; Leukemia; Microscopy, Electron, Scanning; Neoplasms; Neoplastic Stem Cells; Piperidines; Thymidine; Trypan Blue | 1985 |